Literature DB >> 20027081

Comparison of outcomes after extended thymectomy for myasthenia gravis: bilateral thoracoscopic approach versus sternotomy.

Hiroyuki Shiono1, Yoshihisa Kadota, Akio Hayashi, Meinoshin Okumura.   

Abstract

Minimally invasive thymectomy procedures have been proposed for nonthymomatous myasthenia gravis. However, few reports stressed that the lower invasiveness or cosmetic benefits also evaluated the rationale of a thymectomy, which is performed to remove as much thymic tissue as possible. We retrospectively reviewed 30 consecutive patients who underwent a bilateral video-assisted thoracoscopic extended thymectomy (VATET) and compared the results with those of 26 patients who underwent a transsternal extended thymectomy (TSET) to determine the amount of removed thymic tissue and clinical prognosis. The amount of blood loss during the operation for VATET (median 60 mL; range nearly 0 to 940 mL) was significantly lower as compared with that of TSET. The median weight of removed thymic tissue (37.0 g; 18.3 to 100.0 g) and remission rates (1 y: 12.5%; 3 y: 30.8%; 4 y: 44.4%) of VATET were comparable with those of TSET. The VATET group had a similar amount of thymo-fatty tissue removed and feasible clinical outcomes as compared with the TSET group, indicating that VATET provides a proper balance between less invasiveness and radical capability.

Entities:  

Mesh:

Year:  2009        PMID: 20027081     DOI: 10.1097/SLE.0b013e3181c48242

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  9 in total

Review 1.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

2.  Minimally invasive anterior chest wall lifting technique for thoracoscopic mediastinal approach.

Authors:  Hiroyuki Shiono; Tetsuki Sakamoto; Teiko Sakurai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-04-01

3.  Single port VATS mediastinal tumor resection: Taiwan experience.

Authors:  Ching-Yang Wu; Ming-Ju Heish; Ching-Feng Wu
Journal:  Ann Cardiothorac Surg       Date:  2016-03

4.  Improved procedures and comparative results for video-assisted thoracoscopic extended thymectomy for myasthenia gravis.

Authors:  Tomoyuki Nakagiri; Masayoshi Inoue; Yasushi Shintani; Soichiro Funaki; Tomohiro Kawamura; Masato Minami; Mitsunori Ohta; Yoshihisa Kadota; Hiroyuki Shiono; Meinoshin Okumura
Journal:  Surg Endosc       Date:  2014-12-09       Impact factor: 4.584

Review 5.  Minimally invasive surgical procedures for thymic disease in Asia.

Authors:  Meinoshin Okumura; Yasushi Shintani; Mitsunori Ohta; Yoshihisa Kadota; Masayoshi Inoue; Hiroyuki Shiono
Journal:  J Vis Surg       Date:  2017-07-27

6.  Subxiphoid and subcostal arch "Three ports" thoracoscopic extended thymectomy for myasthenia gravis.

Authors:  Qiang Lu; Jinbo Zhao; Juzheng Wang; Zhao Chen; Yong Han; Lijun Huang; Xiaofei Li; Yongan Zhou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 7.  Anterior chest wall lifting methods for mediastinal approach-literature review.

Authors:  Hiroyuki Shiono
Journal:  Mediastinum       Date:  2022-09-25

8.  Uniportal video-assisted thoracoscopic thymectomy: the glove-port with carbon dioxide insufflation.

Authors:  Majed Refai; Diego Gonzalez-Rivas; Gian Marco Guiducci; Alberto Roncon; Michela Tiberi; Francesco Xiumè; Michele Salati; Marco Andolfi
Journal:  Gland Surg       Date:  2020-08

9.  Comparative Short-Term Clinical Outcomes of Mediastinum Tumor Excision Performed by Conventional VATS and Single-Port VATS: Is It Worthwhile?

Authors:  Ching-Feng Wu; Diego Gonzalez-Rivas; Chih-Tsung Wen; Yun-Hen Liu; Yi-Cheng Wu; Yin-Kai Chao; Ming-Ju Hsieh; Ching-Yang Wu; Wei-Hsun Chen
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.